Medicare AdvantageFebruary 20, 2024
Clinical Criteria updates — December 2023
Summary: On December 11, 2023, and January 5, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised. or reviewed to support clinical coding edits.
Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email.
See the explanation/definition for each category of Clinical Criteria below:
- New: newly published criteria
- Revised: addition or removal of medical necessity requirements, new document number
- Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive
Share this notice with other providers in your practice and office staff.
Note:
- The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
- This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.
Effective date | Clinical Criteria number | Clinical Criteria title | New or revised |
March 22, 2024 | *CC-0255 | Loqtorzi (toripalimab-tpzi) | New |
March 22, 2024 | *CC-0256 | Rivfloza (nedosiran) | New |
March 22, 2024 | *CC-0257 | Wainua (eplontersen) | New |
March 22, 2024 | *CC-0185 | Oxlumo (lumasiran) | Revised |
March 22, 2024 | *CC-0107 | Bevacizumab for Non-ophthalmologic Indications | Revised |
March 22, 2024 | *CC-0002 | Colony Stimulating Factor Agents | Revised |
March 22, 2024 | CC-0075 | Rituximab Agents for Non-Oncologic Indications | Revised |
March 22, 2024 | CC-0213 | Voxzogo (vosoritide) | Revised |
March 22, 2024 | CC-0124 | Keytruda (pembrolizumab) | Revised |
March 22, 2024 | *CC-0110 | Perjeta (pertuzumab) | Revised |
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
MULTI-BCBS-CR-051461-24-CPN50533
PUBLICATIONS: March 2024 Provider Newsletter
To view this article online:
Visit https://providernews.anthem.com/ohio/articles/clinical-criteria-updates-december-2023-18291-6-18299
Or scan this QR code with your phone